Therapeutics Acquisition Corp. Human Resources Contracts & Agreements
21 Contracts & Agreements
- Bonus & Incentive Agreements (9 contracts)
- Consulting Agreements (2)
- Employment Agreements (10)
- Form of Performance Stock Unit Award under the POINT Biopharma Global Inc. 2021 Equity Incentive Plan (Filed With SEC on March 27, 2023)
- Consulting Agreement effective January 1, 2022 by and between POINT Biopharma Inc. and Dr. Neil Fleshner (Filed With SEC on March 25, 2022)
- Employment Agreement effective December 1, 2021, as amended, by and between POINT Biopharma USA Inc. and Justyna Kelly (Filed With SEC on March 25, 2022)
- Revised Form of Non-Qualified Stock Option Agreement under the POINT Biopharma Global Inc. 2021 Equity Incentive Plan (Filed With SEC on December 10, 2021)
- Form of Incentive Stock Option Agreement under the POINT Biopharma Global Inc. 2021 Equity Incentive Plan (Filed With SEC on July 1, 2021)
- Form of Restricted Stock Unit Award Agreement under the POINT Biopharma Global Inc. 2021 Equity Incentive Plan (Directors) (Filed With SEC on July 1, 2021)
- Form of Restricted Stock Unit Award Agreement under the POINT Biopharma Global Inc. 2021 Equity Incentive Plan (Employees) (Filed With SEC on July 1, 2021)
- Form of Non-Qualified Stock Option Agreement under the POINT Biopharma Global Inc. 2021 Equity Incentive Plan (Directors) (Filed With SEC on July 1, 2021)
- Form of Non-Qualified Stock Option Agreement under the POINT Biopharma Global Inc. 2021 Equity Incentive Plan (Employees) (Filed With SEC on July 1, 2021)
- POINT Biopharma Global Inc. 2021 Equity Incentive Plan (Filed With SEC on July 1, 2021)
- Employment Agreement, dated as of March 9, 2021, by and between POINT Biopharma Corp. and Donna Husack (Filed With SEC on March 23, 2021)
- Employment Agreement, dated as of April 23, 2020, by and between POINT Biopharma Corp. and Ari Shomair, as amended March 8, 2021 (Filed With SEC on March 23, 2021)
- Employment Agreement, dated as of November 2, 2020, by and between POINT Biopharma Corp. and Justyna Kelly, as amended March 8, 2021 (Filed With SEC on March 23, 2021)
- Employment Agreement, dated as of July 19, 2020, by and between POINT Biopharma USA Inc. and Jessica Jensen (Filed With SEC on March 23, 2021)
- Employment Agreement, dated as of April 23, 2020, by and between POINT Biopharma USA Inc. and Todd Hockemeyer (Filed With SEC on March 23, 2021)
- Consulting Agreement by and between POINT Biopharma Inc. and Dr. Neil Fleshner, dated February 22, 2021 (Filed With SEC on March 23, 2021)
- Employment Agreement, dated as of April 23, 2020, by and between POINT Biopharma Corp. and Michael Gottlieb, as amended March 8, 2021 (Filed With SEC on March 23, 2021)
- Employment Agreement, dated as of July 24, 2020, by and between POINT Biopharma Corp. and William Demers, as amended March 8, 2021 (Filed With SEC on March 23, 2021)
- Employment Agreement, dated as of April 23, 2020, by and between POINT Biopharma Corp. and Joe McCann, as amended March 8, 2021 (Filed With SEC on March 23, 2021)
- Employment Agreement, dated as of April 23, 2020, by and between POINT Biopharma Corp. and Allan Silber, as amended March 8, 2021 (Filed With SEC on March 23, 2021)
- 2020 POINT Biopharma, Inc. Equity Incentive Plan (Filed With SEC on March 23, 2021)
